RBC Analysts See Long-Term Value in Lonza's Merck Acquisition

RBC Capital Markets analysts say Lonza can use its strong balance sheet to create long-term value through its acquisition of Merck KGaA's U.S. contract-drug manufacturing business. The body is truncated before the analysts' estimate for the sites at peak utilization.